Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001993350 | SCV002231119 | pathogenic | Jeune thoracic dystrophy; Nephronophthisis | 2022-09-26 | criteria provided, single submitter | clinical testing | This variant has not been reported in the literature in individuals affected with TTC21B-related conditions. ClinVar contains an entry for this variant (Variation ID: 1451834). For these reasons, this variant has been classified as Pathogenic. This variant is present in population databases (rs771232897, gnomAD 0.01%). This sequence change creates a premature translational stop signal (p.Arg58*) in the TTC21B gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in TTC21B are known to be pathogenic (PMID: 18327258, 21068128, 21258341, 23559409, 24876116, 25492405, 27491411, 29068549). |
Fulgent Genetics, |
RCV005025514 | SCV005653393 | likely pathogenic | Asphyxiating thoracic dystrophy 4; Nephronophthisis 12 | 2024-02-22 | criteria provided, single submitter | clinical testing |